Recommendations on the management of pulmonary hypertension in clinical practice.
about
Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analysesPulmonary arterial hypertension: a comparison between children and adultsAssessment of right ventricular structure and function in pulmonary hypertension.Giant, dissecting, high-pressure pulmonary artery aneurysm: case report of a 1-year natural courseSerum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressureCardiac manifestations in systemic sclerosis.Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settingsIntegrated care and optimal management of pulmonary arterial hypertensionWhen to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonismParadoxical increase of pulmonary vascular resistance during testing of inhaled iloprost.[Pulmonary hypertension in scleroderma: about 12 cases]Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases.Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie studyThe management of pulmonary hypertension in children.Characterization of the vasodilatory action of testosterone in the human pulmonary circulation.Treatment of pediatric pulmonary hypertensionPulmonary hypertension-"state of the art" management in 2012.
P2860
Q21245613-0063304F-9056-4166-8D07-093961C6CE50Q27687320-2689B5AE-6977-422C-BF75-A89B675FE66BQ30473048-C0EE8BD2-DCD4-4537-A9B9-55E88EAF5A98Q30502967-3DD515EF-F315-4FD0-AEA4-134A10FA0ED2Q34143652-E3507BCB-9C0A-4C38-9C29-7247B6C17F72Q34251904-35DC608D-ADD4-4076-9448-110ADE8F89F8Q34254924-A358AE3E-CDCC-469B-8C8A-67D91F69FF0AQ34417785-2657EF2B-B9AA-4666-9F65-ADF257BAC84AQ34999542-9EF00CFB-355F-4D87-97A6-B4F550138713Q35554571-C3CE00BB-1B7B-4B31-9779-43DFC509483CQ35581973-642B4FD8-6DE9-4DE9-A66C-918C5553BA5CQ35767581-3902AE84-2BCD-404E-B55B-3FF7F656E682Q36930712-0B7AEB71-F32F-4F48-B000-A711B5BDDBC0Q37100627-74346499-47BD-4328-A611-2CDA98DEAB53Q37125318-D067EC4E-44D9-49DD-B4BB-2F90351A288EQ37145656-DF4494EE-4B3B-4578-B712-A2FAACA93951Q37230469-44B19C6A-F944-4F65-ACCE-AE5FD8484807Q37387305-E2E42780-1213-4C91-8D66-F857D7E29321
P2860
Recommendations on the management of pulmonary hypertension in clinical practice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Recommendations on the management of pulmonary hypertension in clinical practice.
@ast
Recommendations on the management of pulmonary hypertension in clinical practice.
@en
type
label
Recommendations on the management of pulmonary hypertension in clinical practice.
@ast
Recommendations on the management of pulmonary hypertension in clinical practice.
@en
prefLabel
Recommendations on the management of pulmonary hypertension in clinical practice.
@ast
Recommendations on the management of pulmonary hypertension in clinical practice.
@en
P2860
P1433
P1476
Recommendations on the management of pulmonary hypertension in clinical practice.
@en
P2093
British Cardiac Society Guidel ...... ritish Society of Rheumatology
P2860
P407
P478
86 Suppl 1
P577
2001-09-01T00:00:00Z